DILETTI, ROBERTO
DILETTI, ROBERTO
DIPARTIMENTO DI MEDICINA (attivo dal 01/01/2014 al 31/10/2020)
1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis of the ABSORB and the SPIRIT Trials.
2014 Muramatsu, T; Onuma, Y; van Geuns, Rj; Chevalier, B; Patel, Tm; Seth, A; Diletti, Roberto; García García, Hm; Dorange, Cc; Veldhof, S; Cheong, Wf; Ozaki, Y; Whitbourn, R; Bartorelli, A; Stone, Gw; Abizaid, A; Serruys, Pw; ABSORB Cohort B., the ABSORB EXTEND; the SPIRIT FIRST II, Iii; Iv, Investigators
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm.
2011 Diletti, Roberto; Onuma, Y; Farooq, V; Gomez Lara, J; Brugaletta, S; van Geuns, Rj; Regar, E; de Bruyne, B; Dudek, D; Thuesen, L; Chevalier, B; Mcclean, D; Windecker, S; Whitbourn, R; Smits, P; Koolen, J; Meredith, I; Li, D; Veldhof, S; Rapoza, R; Garcia Garcia, Hm; Ormiston, Ja; Serruys, Pw
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
2011 Gomez Lara, J; Brugaletta, S; Diletti, Roberto; Garg, S; Onuma, Y; Gogas, Bd; van Geuns, Rj; Dorange, C; Veldhof, S; Rapoza, R; Whitbourn, R; Windecker, S; Garcia Garcia, Hm; Regar, E; Serruys, Pw
ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
2012 Diletti, Roberto; Serruys, Pw; Farooq, V; Sudhir, K; Dorange, C; Miquel Hebert, K; Veldhof, S; Rapoza, R; Onuma, Y; Garcia Garcia, Hm; Chevalier, B.
Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold.
2012 Gómez Lara, J; Brugaletta, S; Diletti, Roberto; Gogas, Bd; Farooq, V; Onuma, Y; Gobbens, P; Van Es, Ga; García García, Hm; Serruys, Pw
Angiographic and histological results following implantation of a novel stent-on-a-wire in the animal model.
2012 Diletti, Roberto; Garcia Garcia, Hm; van Geuns, Rj; Farooq, V; Bailey, L; Rousselle, S; Kopia, G; Easterbrook, W; Pomeranz, M; Serruys, Pw
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.
2012 Gomez Lara, J; Diletti, Roberto; Brugaletta, S; Onuma, Y; Farooq, V; Thuesen, L; Mcclean, D; Koolen, J; Ormiston, Ja; Windecker, S; Whitbourn, R; Dudek, D; Dorange, C; Veldhof, S; Rapoza, R; Regar, E; Garcia Garcia, Hm; Serruys, Pw
Assessment of coronary atherosclerosis progression and regression at bifurcations using combined IVUS and OCT.
2011 Diletti, Roberto; Garcia Garcia, Hm; Gomez Lara, J; Brugaletta, S; Wykrzykowska, Jj; van Ditzhuijzen, N; van Geuns, Rj; Regar, E; Ambrosio, Giuseppe; Serruys, Pw
Assessment of plaque evolution in coronary bifurcations located beyond everolimus eluting scaffolds: serial intravascular ultrasound virtual histology study.
2013 Lee, Is; Bourantas, Cv; Muramatsu, T; Gogas, Bd; Heo, Jh; Diletti, Roberto; Farooq, V; Zhang, Y; Onuma, Y; Serruys, Pw; Garcia Garcia, Hm
Bioresorbable scaffolds in the treatment of coronary artery disease.
2013 Zhang, Y; Bourantas, Cv; Farooq, V; Muramatsu, T; Diletti, Roberto; Onuma, Y; Garcia Garcia, Hm; Serruys, Pw
Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study.
2013 Bourantas, Cv; Garcia Garcia, Hm; Farooq, V; Maehara, A; Xu, K; Généreux, P; Diletti, Roberto; Muramatsu, T; Fahy, M; Weisz, G; Stone, Gw; Serruys, Pw
Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial.
2013 Diletti, Roberto; Garcia Garcia, Hm; Bourantas, Cv; van Geuns, Rj; Van Mieghem, Nm; Agostoni, P; Muramatsu, T; Farooq, V; Spencer, R; De Schepper, J; Pomeranz, M; Stella, P; Serruys, Pw
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial.
2013 Diletti, Roberto; Farooq, V; Girasis, C; Bourantas, C; Onuma, Y; Heo, Jh; Gogas, Bd; van Geuns, Rj; Regar, E; de Bruyne, B; Dudek, D; Thuesen, L; Chevalier, B; Mcclean, D; Windecker, S; Whitbourn, Rj; Smits, P; Koolen, J; Meredith, I; Li, X; Miquel Hebert, K; Veldhof, S; Garcia Garcia, Hm; Ormiston, Ja; Serruys, Pw
Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial.
2013 Diletti, Roberto; Garcia Garcia, Hm; Bourantas, Cv; van Geuns, Rj; Van Mieghem, Nm; Vranckx, P; Zhang, Yj; Farooq, V; Iqbal, J; Wykrzykowska, Jj; de Vries, T; Swart, M; Teunissen, Y; Negoita, M; van Leeuwen, F; Silber, S; Windecker, S; Serruys, Pw; RESOLUTE All Comers, Investigators
Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.
2012 Farooq, V; Vergouwe, Y; Räber, L; Vranckx, P; Garcia Garcia, H; Diletti, Roberto; Kappetein, Ap; Morel, Ma; de Vries, T; Swart, M; Valgimigli, M; Dawkins, Kd; Windecker, S; Steyerberg, Ew; Serruys, Pw
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.
2011 Brugaletta, S; Garcia Garcia, Hm; Diletti, Roberto; Gomez Lara, J; Garg, S; Onuma, Y; Shin, Es; van Geuns, Rj; de Bruyne, B; Dudek, D; Thuesen, L; Chevalier, B; Mcclean, D; Windecker, S; Whitbourn, R; Dorange, C; Veldhof, S; Rapoza, R; Sudhir, K; Bruining, N; Ormiston, Ja; Serruys, Pw
Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial.
2014 Zhang, Yj; Bourantas, Cv; Muramatsu, T; Iqbal, J; Farooq, V; Diletti, Roberto; Campos, Ca; Onuma, Y; Garcia Garcia, Hm; Serruys, Pw
Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials.
2012 Brugaletta, S; Gomez Lara, J; Diletti, Roberto; Farooq, V; van Geuns, Rj; de Bruyne, B; Dudek, D; Garcia Garcia, Hm; Ormiston, Ja; Serruys, Pw
Comparison of plaque prolapse in consecutive patients treated with Xience V and Taxus Liberte stents.
2012 Shen, Zj; Brugaletta, S; Garcia Garcia, Hm; Ligthart, J; Gomez Lara, J; Diletti, Roberto; Sarno, G; Witberg, K; Serruys, Pw
Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice.
2013 Van Mieghem, Nm; van der Boon, Rm; Faqiri, E; Diletti, Roberto; Schultz, C; van Geuns, Rj; Serruys, Pw; Kappetein, Ap; van Domburg, Rt; de Jaegere, Pp
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis of the ABSORB and the SPIRIT Trials. | 2014 | Muramatsu, T; Onuma, Y; van Geuns, Rj; Chevalier, B; Patel, Tm; Seth, A; Diletti, Roberto; García García, Hm; Dorange, Cc; Veldhof, S; Cheong, Wf; Ozaki, Y; Whitbourn, R; Bartorelli, A; Stone, Gw; Abizaid, A; Serruys, Pw; ABSORB Cohort B., the ABSORB EXTEND; the SPIRIT FIRST II, Iii; Iv, Investigators | |
| 6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm. | 2011 | Diletti, Roberto; Onuma, Y; Farooq, V; Gomez Lara, J; Brugaletta, S; van Geuns, Rj; Regar, E; de Bruyne, B; Dudek, D; Thuesen, L; Chevalier, B; Mcclean, D; Windecker, S; Whitbourn, R; Smits, P; Koolen, J; Meredith, I; Li, D; Veldhof, S; Rapoza, R; Garcia Garcia, Hm; Ormiston, Ja; Serruys, Pw | |
| A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. | 2011 | Gomez Lara, J; Brugaletta, S; Diletti, Roberto; Garg, S; Onuma, Y; Gogas, Bd; van Geuns, Rj; Dorange, C; Veldhof, S; Rapoza, R; Whitbourn, R; Windecker, S; Garcia Garcia, Hm; Regar, E; Serruys, Pw | |
| ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. | 2012 | Diletti, Roberto; Serruys, Pw; Farooq, V; Sudhir, K; Dorange, C; Miquel Hebert, K; Veldhof, S; Rapoza, R; Onuma, Y; Garcia Garcia, Hm; Chevalier, B. | |
| Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold. | 2012 | Gómez Lara, J; Brugaletta, S; Diletti, Roberto; Gogas, Bd; Farooq, V; Onuma, Y; Gobbens, P; Van Es, Ga; García García, Hm; Serruys, Pw | |
| Angiographic and histological results following implantation of a novel stent-on-a-wire in the animal model. | 2012 | Diletti, Roberto; Garcia Garcia, Hm; van Geuns, Rj; Farooq, V; Bailey, L; Rousselle, S; Kopia, G; Easterbrook, W; Pomeranz, M; Serruys, Pw | |
| Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study. | 2012 | Gomez Lara, J; Diletti, Roberto; Brugaletta, S; Onuma, Y; Farooq, V; Thuesen, L; Mcclean, D; Koolen, J; Ormiston, Ja; Windecker, S; Whitbourn, R; Dudek, D; Dorange, C; Veldhof, S; Rapoza, R; Regar, E; Garcia Garcia, Hm; Serruys, Pw | |
| Assessment of coronary atherosclerosis progression and regression at bifurcations using combined IVUS and OCT. | 2011 | Diletti, Roberto; Garcia Garcia, Hm; Gomez Lara, J; Brugaletta, S; Wykrzykowska, Jj; van Ditzhuijzen, N; van Geuns, Rj; Regar, E; Ambrosio, Giuseppe; Serruys, Pw | |
| Assessment of plaque evolution in coronary bifurcations located beyond everolimus eluting scaffolds: serial intravascular ultrasound virtual histology study. | 2013 | Lee, Is; Bourantas, Cv; Muramatsu, T; Gogas, Bd; Heo, Jh; Diletti, Roberto; Farooq, V; Zhang, Y; Onuma, Y; Serruys, Pw; Garcia Garcia, Hm | |
| Bioresorbable scaffolds in the treatment of coronary artery disease. | 2013 | Zhang, Y; Bourantas, Cv; Farooq, V; Muramatsu, T; Diletti, Roberto; Onuma, Y; Garcia Garcia, Hm; Serruys, Pw | |
| Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study. | 2013 | Bourantas, Cv; Garcia Garcia, Hm; Farooq, V; Maehara, A; Xu, K; Généreux, P; Diletti, Roberto; Muramatsu, T; Fahy, M; Weisz, G; Stone, Gw; Serruys, Pw | |
| Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial. | 2013 | Diletti, Roberto; Garcia Garcia, Hm; Bourantas, Cv; van Geuns, Rj; Van Mieghem, Nm; Agostoni, P; Muramatsu, T; Farooq, V; Spencer, R; De Schepper, J; Pomeranz, M; Stella, P; Serruys, Pw | |
| Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. | 2013 | Diletti, Roberto; Farooq, V; Girasis, C; Bourantas, C; Onuma, Y; Heo, Jh; Gogas, Bd; van Geuns, Rj; Regar, E; de Bruyne, B; Dudek, D; Thuesen, L; Chevalier, B; Mcclean, D; Windecker, S; Whitbourn, Rj; Smits, P; Koolen, J; Meredith, I; Li, X; Miquel Hebert, K; Veldhof, S; Garcia Garcia, Hm; Ormiston, Ja; Serruys, Pw | |
| Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial. | 2013 | Diletti, Roberto; Garcia Garcia, Hm; Bourantas, Cv; van Geuns, Rj; Van Mieghem, Nm; Vranckx, P; Zhang, Yj; Farooq, V; Iqbal, J; Wykrzykowska, Jj; de Vries, T; Swart, M; Teunissen, Y; Negoita, M; van Leeuwen, F; Silber, S; Windecker, S; Serruys, Pw; RESOLUTE All Comers, Investigators | |
| Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. | 2012 | Farooq, V; Vergouwe, Y; Räber, L; Vranckx, P; Garcia Garcia, H; Diletti, Roberto; Kappetein, Ap; Morel, Ma; de Vries, T; Swart, M; Valgimigli, M; Dawkins, Kd; Windecker, S; Steyerberg, Ew; Serruys, Pw | |
| Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study. | 2011 | Brugaletta, S; Garcia Garcia, Hm; Diletti, Roberto; Gomez Lara, J; Garg, S; Onuma, Y; Shin, Es; van Geuns, Rj; de Bruyne, B; Dudek, D; Thuesen, L; Chevalier, B; Mcclean, D; Windecker, S; Whitbourn, R; Dorange, C; Veldhof, S; Rapoza, R; Sudhir, K; Bruining, N; Ormiston, Ja; Serruys, Pw | |
| Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial. | 2014 | Zhang, Yj; Bourantas, Cv; Muramatsu, T; Iqbal, J; Farooq, V; Diletti, Roberto; Campos, Ca; Onuma, Y; Garcia Garcia, Hm; Serruys, Pw | |
| Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials. | 2012 | Brugaletta, S; Gomez Lara, J; Diletti, Roberto; Farooq, V; van Geuns, Rj; de Bruyne, B; Dudek, D; Garcia Garcia, Hm; Ormiston, Ja; Serruys, Pw | |
| Comparison of plaque prolapse in consecutive patients treated with Xience V and Taxus Liberte stents. | 2012 | Shen, Zj; Brugaletta, S; Garcia Garcia, Hm; Ligthart, J; Gomez Lara, J; Diletti, Roberto; Sarno, G; Witberg, K; Serruys, Pw | |
| Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. | 2013 | Van Mieghem, Nm; van der Boon, Rm; Faqiri, E; Diletti, Roberto; Schultz, C; van Geuns, Rj; Serruys, Pw; Kappetein, Ap; van Domburg, Rt; de Jaegere, Pp |